Expertise in
9
conditions

Patrizia Giannatempo

Milan, IT 
Expertise in
9
conditions
Milan, IT 

Overview

Patrizia Giannatempo practices practicing medicine in Milan, Italy.

Ms. Giannatempo is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Penile Cancer, Cystectomy, and Orchiectomy.

She is actively involved in clinical research, co-authoring 165 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

Milan, Italy
Other Locations
Italiana, Italy
Messina, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab (MK-3475) Before Cystectomy for Patients With Muscle-invasive Urothelial Bladder Cancer.
An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab (MK-3475) Before Cystectomy for Patients With Muscle-invasive Urothelial Bladder Cancer.
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drug: Pembrolizumab
Study Phase: Phase 2
An Open Label, Single-arm, Phase 2 Study of Pembrolizumab and Nanoparticle Albumin-bound Paclitaxel in Patients With Metastatic Urothelial Carcinoma After Chemotherapy Failure; the PEANUT Study
An Open Label, Single-arm, Phase 2 Study of Pembrolizumab and Nanoparticle Albumin-bound Paclitaxel in Patients With Metastatic Urothelial Carcinoma After Chemotherapy Failure; the PEANUT Study
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Drug
Study Phase: Phase 2
Phase II Study of Single-agent Pazopanib (Votrient®) for Patients With Relapsed or Refractory Germ-cell Tumors (GCT).
Phase II Study of Single-agent Pazopanib (Votrient®) for Patients With Relapsed or Refractory Germ-cell Tumors (GCT).
Enrollment Status: Completed
Publish Date: May 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Study of the Aurora Kinase A Inhibitor Alisertib (MLN8237) in Patients With Relapsed or Refractory Transitional-cell Carcinoma of the Bladder and Urothelial Tract
A Phase 2 Study of the Aurora Kinase A Inhibitor Alisertib (MLN8237) in Patients With Relapsed or Refractory Transitional-cell Carcinoma of the Bladder and Urothelial Tract
Enrollment Status: Completed
Publish Date: April 11, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

165 Total Publications

Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.
Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.
Journal: Expert opinion on biological therapy
Published: August 29, 2026

Frequently Asked Questions about Patrizia Giannatempo

Is Patrizia Giannatempo a top-rated expert for Urothelial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Patrizia Giannatempo is classified as an Elite expert for Urothelial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Patrizia Giannatempo participate in research or clinical trials?

Yes. Patrizia Giannatempo has published 165 articles and abstracts on conditions like Urothelial Cancer. You can view a list of Patrizia Giannatempo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Giannatempo's expertise for a condition
ConditionClose
View All 15 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile